人工合成抗菌藥 (4)課件_第1頁
人工合成抗菌藥 (4)課件_第2頁
人工合成抗菌藥 (4)課件_第3頁
人工合成抗菌藥 (4)課件_第4頁
人工合成抗菌藥 (4)課件_第5頁
已閱讀5頁,還剩33頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

人工合成抗菌藥2_1syntheticantimicrobialdrugs人工合成抗菌藥2_1ClassificationQuinolonesSulfonamidesNitrofuransandnitroimidazole(Metronidazole)人工合成抗菌藥2_1taskUnderstandingthemechanismsofdrugaction,pharmacokineticsanddruginteractionsMasteringantibacterialactivities,therapueticapplicationsandthemajoradversereactions.人工合成抗菌藥2_1Fluoroquinolones人工合成抗菌藥2_1ClassificationofquinolonesThefirstgeneration:nalidixicacid(1962)Thesecondgeneration:pipemidicacid(1973)Thethirdgeneration:fluoroquinolones(1980s)Theforthgeneration:fluoroquinolones(theendof1990s)人工合成抗菌藥2_1FluoroquinolonesNorfloxacinCiprofloxacinOfloxacinLevofloxacinLomefloxacinFleroxacinSparfloxacinMoxifloxacin人工合成抗菌藥2_1Antibacterialspectrum1.Broad-spectrum;GoodactivityagainstG-.Includinglegionella,pseudomonasaeruginasaandMRSA.2.Someiseffecttotuberculebacillus,mycoplasma,chlamydiaandanaerobianetc.Sparfloxacin’sactivityisthestrongest.3.TheforthgenerationsuchasmoxifloxacinimprovedactivityagainstG+.人工合成抗菌藥2_1MechanismofactionInhibitingtypeIItopoisomerases(DNA

gyrase)andtopoisomeraseIV人工合成抗菌藥2_1人工合成抗菌藥2_1PharmacokineticsWellabsorptionafteroraladministrationanddistributionwidelyinbodyfluidsandtissues.TherelativelylongT1/2Renalclearancepredominatesformostfluoroquinolones.人工合成抗菌藥2_1ResistanceCrossresistanceamongthedrugsofthisclass;Commondrug-risistancebacteria:Staphylococcusaureus,enterococcus,Escherichiacoli

and

Pseudomonasaeruginosa

etc.人工合成抗菌藥2_1MechanismofresistanceMutationsinthebacterialchromosomalgenesencodinggyrA,ortopoisomeraseIV.Achangeinthepermeabilityoftheorganism;e.g.Escherichiacoli

Activetransportofthedrugoutofthebacteria

;e.g.

StaphylococcusaureusClinicalapplicationUrinarytractinfections:urethritis,cervicitis,prostatitis.thefirstchoiceisciprofloxacin,gatifloxacinorofloxacinRespiratoryinfectionsIntestinalinfectionandtyphusBone,joint,skin,parenchyma,surgery,E.N.Tinfections.人工合成抗菌藥2_1Adverse

reaction

GastrointestinaleffectsCNSreaction:excitedSkinandphotosensitivityCartilagedamageLiverorrenalfunctionallesion,Achillestendinitis,hearttoxicity,eyetoxicity.人工合成抗菌藥2_1ContraindicationChildren,pregnantwomen

,sucklingwomen,insanepatientorpatientofepilepsyhistoryAllergicpatientCommonfluoroquinolonesinclinicNorfloxacinitsabsorptionisaffectedbyfood.(35-45%)LowplasmadrugconcentrationHighurineandintestinaltractdrugconcentrationNoclinicalvalueformycoplasma,chlamydia,legionella人工合成抗菌藥2_1CiprofloxacinThestrongestantibacterialactioninvitroBioavailabilityis38-60%StrongeffectforG-bacillianddrug-resistanceG+/G–TherapeuticapplicationismainlyforinfectionsofotherdrugresistanceG-bacilli.Noeffectformostanaerobian.ThesameantibacterialcharactertociprofloxacinInaddition,ofloxacinhaseffectformycobacteriumtuberculosis,chlamydiatrachomatisandsomeanaerobian.Thesecond-lineagentfortreatmentoftuberculosisLevofloxacinItsantibacterialactivityisdoubleofofloxacin’s.

Ofloxacin人工合成抗菌藥2_1

goodabsorptionbyoraladministrationItsbioacailabilityisabout99%.DistributedwidelyinbodyfluidsandtissuesStrongantibacterialactivityinvivoAdversereactionismore.Fleroxacin人工合成抗菌藥2_1SulfnamidesBroadspectrum,stable,convenience,easytoproduce,cheap人工合成抗菌藥2_1Chemicalconstitution

O

R2NH

S

NH

R1O

sulfanilamide人工合成抗菌藥2_1classificationSystemicinfection:Short-acting:SIZMiddle-acting:SD、SMZProlonged-acting:SMM、SDMIntestinaltract:SASPExternalusetoLocalinfection:SA-Na、SD-Ag、SML人工合成抗菌藥2_1AntibacterialspectrumBroad-spectrumbacteriostaticItiseffectivetomostofG+andG-,chlamydia,plasmodiumandactinomycesSML、SD-AgexternalusediseffecttoPseudomonasaeruginosa

ActionofmechanismDihydropteroicacidL-glumateDihydropteroicacidsynthaseFH2FH2reductaseFH4bacteriumPurine,PyrimidineSyntheticproteinTMPPABA人工合成抗菌藥2_1MechanismofactionSulfonamidescompletitivelyinhibitdihydropteroatesynthaseandpreventnormalbacterialutilizationofPABA.人工合成抗菌藥2_1MechanismofresistanceLoweredaffinityofdihydropteroatesynthasetosulfonamides;Decreasedbacterialpermeabilityoractiveeffluxofsulfonamides;Analterativemetabolicpathwayforsynthesisofanessentialmetaboliteorover-productionofPABA.CROSS-RESISTANCE人工合成抗菌藥2_1PharmacokineticsSystemicinfectiondrugsbyoraladministrationisabsorbedwellanddistributedwidely.人工合成抗菌藥2_1AdverseeffectUrinarytractdisturbancesAllergicreactionHematopoieticsystemdisordersNervoussystemreactionMiscellaneousreaction:nausea,vomiting,diarrhea,headache

,etc人工合成抗菌藥2_1Trimethoprim(TMP)TMPinhibitsbacterialdihydrofolicacidreductase.TMPgiventogetherwithsulfonamides,producessequentialblockingoffolicacidsynthesis,resultinginmarkedenhancement(synergism)ofthebacteriostaticactivity.ActionofmechanismDihydropteroicacidL-glumateDihydropteroicacidsynthaseFH2FH2reductaseFH4bacteriumPurine,PyrimidineSyntheticproteinTMPPABA人工合成抗菌藥2_1sulfadiazine(SD)SDachievestherapeuticconcentrationsincerebrospinalfluidandisafirst-linetherapyfortreatmentofepidemiccerebrospinalmeningitis.人工合成抗菌藥2_1Sulfisoxazole(SIZ)andsulfamethoxazole(SMZ)SIZandSMZareoftenusedtotreaturinarytractinfections.SMZgiventogetherwithTMP,SMZcoisusedwidelyforrespiratorytractinfections.人工合成抗菌藥2_1SASPitselfisnoantibacterialactivity.Resolvingintosulfapyridine

and5-aminosalicylateinintestinaltractacu

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論